BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30405442)

  • 1. Barttin Regulates the Subcellular Localization and Posttranslational Modification of Human Cl
    Wojciechowski D; Kovalchuk E; Yu L; Tan H; Fahlke C; Stölting G; Alekov AK
    Front Physiol; 2018; 9():1490. PubMed ID: 30405442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and analyses of R8L barttin knockin mouse.
    Nomura N; Tajima M; Sugawara N; Morimoto T; Kondo Y; Ohno M; Uchida K; Mutig K; Bachmann S; Soleimani M; Ohta E; Ohta A; Sohara E; Okado T; Rai T; Jentsch TJ; Sasaki S; Uchida S
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F297-307. PubMed ID: 21593186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of renal ClC-K chloride channels depends on an intact N terminus of their accessory subunit barttin.
    Wojciechowski D; Thiemann S; Schaal C; Rahtz A; de la Roche J; Begemann B; Becher T; Fischer M
    J Biol Chem; 2018 Jun; 293(22):8626-8637. PubMed ID: 29674316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.
    Steinke KV; Gorinski N; Wojciechowski D; Todorov V; Guseva D; Ponimaskin E; Fahlke C; Fischer M
    J Biol Chem; 2015 Jul; 290(28):17390-400. PubMed ID: 26013830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine.
    Sahbani D; Strumbo B; Tedeschi S; Conte E; Camerino GM; Benetti E; Montini G; Aceto G; Procino G; Imbrici P; Liantonio A
    Front Pharmacol; 2020; 11():327. PubMed ID: 32256370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Dent disease 1 cellular models reveal biological processes underlying ClC-5 loss-of-function.
    Durán M; Burballa C; Cantero-Recasens G; Butnaru CM; Malhotra V; Ariceta G; Sarró E; Meseguer A
    Hum Mol Genet; 2021 Jul; 30(15):1413-1428. PubMed ID: 33987651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHHC7-mediated palmitoylation of the accessory protein barttin critically regulates the functions of ClC-K chloride channels.
    Gorinski N; Wojciechowski D; Guseva D; Abdel Galil D; Mueller FE; Wirth A; Thiemann S; Zeug A; Schmidt S; Zareba-Kozioł M; Wlodarczyk J; Skryabin BV; Glage S; Fischer M; Al-Samir S; Kerkenberg N; Hohoff C; Zhang W; Endeward V; Ponimaskin E
    J Biol Chem; 2020 May; 295(18):5970-5983. PubMed ID: 32184353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene.
    Hayama A; Rai T; Sasaki S; Uchida S
    Histochem Cell Biol; 2003 Jun; 119(6):485-93. PubMed ID: 12761627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology and pathophysiology of ClC-K/barttin channels.
    Fahlke C; Fischer M
    Front Physiol; 2010; 1():155. PubMed ID: 21423394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-causing dysfunctions of barttin in Bartter syndrome type IV.
    Janssen AG; Scholl U; Domeyer C; Nothmann D; Leinenweber A; Fahlke C
    J Am Soc Nephrol; 2009 Jan; 20(1):145-53. PubMed ID: 18776122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Membrane Insertion of CLC-K by V33L Barttin Results in Loss of Hearing, but Leaves Kidney Function Intact.
    Tan H; Bungert-Plümke S; Fahlke C; Stölting G
    Front Physiol; 2017; 8():269. PubMed ID: 28555110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barttin increases surface expression and changes current properties of ClC-K channels.
    Waldegger S; Jeck N; Barth P; Peters M; Vitzthum H; Wolf K; Kurtz A; Konrad M; Seyberth HW
    Pflugers Arch; 2002 Jun; 444(3):411-8. PubMed ID: 12111250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter syndrome.
    Hebert SC
    Curr Opin Nephrol Hypertens; 2003 Sep; 12(5):527-32. PubMed ID: 12920401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dent disease: A window into calcium and phosphate transport.
    Anglani F; Gianesello L; Beara-Lasic L; Lieske J
    J Cell Mol Med; 2019 Nov; 23(11):7132-7142. PubMed ID: 31472005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop disorders: insights derived from defined genotypes.
    Jeck N; Seyberth HW
    Nephron Physiol; 2011; 118(1):p7-14. PubMed ID: 21071987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of zebrafish ClC-K/barttin channels in apical kidney chloride reabsorption.
    Pérez-Rius C; Castellanos A; Gaitán-Peñas H; Navarro A; Artuch R; Barrallo-Gimeno A; Estévez R
    J Physiol; 2019 Aug; 597(15):3969-3983. PubMed ID: 31177533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cl
    Chang MH; Brown MR; Liu Y; Gainullin VG; Harris PC; Romero MF; Lieske JC
    J Biol Chem; 2020 Feb; 295(6):1464-1473. PubMed ID: 31852738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel down-regulation of chloride channel CLC-K1 and barttin mRNA in the thin ascending limb of the rat nephron by furosemide.
    Wolf K; Meier-Meitinger M; Bergler T; Castrop H; Vitzthum H; Riegger GA; Kurtz A; Krämer BK
    Pflugers Arch; 2003 Sep; 446(6):665-71. PubMed ID: 12759757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice.
    Nomura N; Kamiya K; Ikeda K; Yui N; Chiga M; Sohara E; Rai T; Sakaki S; Uchida S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):544-9. PubMed ID: 24189473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.
    Cheng CJ; Lo YF; Chen JC; Huang CL; Lin SH
    J Physiol; 2017 Aug; 595(16):5573-5586. PubMed ID: 28555925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.